The Leukemia and Lymphoma Society (LLS) National Research Registry
Part of paid clinical trials in Rye Brook, New York.
- Sponsor
- Blood Cancer United
- Study ID
- NCT04806295
- Status
- Recruiting
Conditions
- Blood Cancer
Eligibility Criteria
- Sex
- ALL
- Age
- 21 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- any/all treatments for blood cancer — OTHERFollowing people undergoing any/all treatments for blood cancer.
Study Details
The Leukemia and Lymphoma Society (LLS) has built a National Research Registry to evaluate real world experiences and medical outcomes for people with blood cancer, before, during, and after blood cancer treatments.
Key Dates
- Start date
- Jul 24, 2017
- Status verified
- Apr 2022
- Primary completion
- Jul 23, 2027
- Completion
- Jul 23, 2027
Study Design
- Enrollment
- 1,000 participants (estimated)
Primary Outcome Measure
LLS will monitor outcomes of people being treated for blood cancer. [ Time Frame: 10 years ]
Central Contacts
- Larry Saltzman, MD844-696-7228
- Brian J Chadwick, BS RN9144145788
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Lymphoma and Leukemia Society | Rye Brook | New York | 10573 |
Find similar trials in Rye Brook, NY
By research site
Related Studies
- IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic CancersPHASE1/PHASE2 · Recruiting · Indapta Therapeutics, INC. · Los Angeles, California
- A Music Therapy Study for Blood Cancer Survivors With Cognitive DifficultiesRecruiting · Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey
- Defining the Role of Palliative carE for Patients With Hematologic Malignancies Undergoing Adoptive CEllular TherapyRecruiting · Massachusetts General Hospital · Boston, Massachusetts
- Immune Profiling for Cancer Immunotherapy ResponseRecruiting · Dartmouth-Hitchcock Medical Center · Lebanon, New Hampshire